Formulary Exclusion Lists 2026: If Your Plan Dropped Wegovy or Zepbound

GLP-1 Prescriptions Editorial Team · July 17, 2026 · 8 min read
Affiliate Disclosure: This site contains affiliate links to telehealth providers. If you click a link and make a purchase, we may receive a commission at no extra cost to you. All opinions are our own. Links marked "Paid link" are sponsored placements. See our full disclosure.

Formulary Exclusions: When Your Coverage Disappears

Formulary exclusion means your plan has removed a medication from its covered drug list entirely. This is different from moving it to a higher tier (where it's still covered, just more expensive). An excluded medication receives zero coverage — as if it doesn't exist in the plan's universe.

Some plans excluded specific GLP-1s in their 2026 formulary updates. This happens when the plan negotiates exclusive preferred status with one manufacturer over another (covering only Zepbound and excluding Wegovy, or vice versa) or when the plan decides to exclude all anti-obesity medications from coverage.

What to Do If You're Affected

Check if an alternative is covered. If your plan excluded Wegovy but covers Zepbound (or vice versa), switching to the covered option may be the fastest path to continued treatment. Your prescriber can manage the clinical transition.

Request a formulary exception. Even when a drug is excluded, you can request a formulary exception based on medical necessity. The bar is higher than a standard PA, but it's possible — particularly if you have documented intolerance or treatment failure with the covered alternative.

Use manufacturer channels. NovoCare (Wegovy) and LillyDirect (Zepbound) offer savings programs that may make the medication affordable even without insurance coverage.

Consider compounded alternatives. Cash-pay compounded semaglutide or tirzepatide through licensed telehealth platforms bypasses the formulary entirely at $149-$399/month.

Editor's Choice

Embody

Top Pick — $400 CPA

From $249/mo

Injectable semaglutide only. Compounded — not FDA-approved.

Check Eligibility →

Advocacy: Pushing Back on Exclusions

If your employer self-funds their health plan, the formulary exclusion was a benefits design decision — and it can be reversed. Contact your HR benefits team and make the case for coverage inclusion. Employee advocacy is one of the most effective drivers of formulary changes in employer-sponsored plans.

If you're on a marketplace or government plan, the advocacy pathway is more complex but still exists: file a grievance through your plan's formal complaint process, contact your state insurance commissioner, and document the impact of the exclusion on your health outcomes.

Protecting Yourself for Next Year

Formulary changes are announced annually during open enrollment. Before selecting or renewing your plan for the next year, check the prospective formulary for your GLP-1 medication. If your current plan is dropping coverage, open enrollment is your opportunity to switch to a plan that covers what you need.

Insurance brokers and marketplace navigators can help you compare formularies across available plans. The lowest premium isn't always the best value if it comes with a formulary that excludes your most expensive medication.

Brand-Name Rx

Sesame Care

Brand-Name Marketplace

From $99/visit

FDA-approved brand-name medications only (Wegovy, Zepbound, Foundayo). Not compounded.

Check Eligibility →
$100 Off

Found Health

$100 Off Promo

From $129/mo

Compounded — not FDA-approved.

Check Eligibility →
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with potential side effects including nausea, vomiting, diarrhea, and in rare cases, pancreatitis or thyroid tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult a licensed healthcare provider before starting any medication. Compounded medications are not FDA-approved for safety, efficacy, or quality.